# FDA recall D-0520-2017

> **Amerisource Health Services** · Class II · drug recall initiated 2017-02-03.

## Product

GlipiZIDE Extended-release tablets, 2.5 mg, 30-count carton (NDC 68084-295-21), Individual dose (NDC 68084-395-11), Rx Only, Packaged and Distributed by American Health Packaging, Columbus, Ohio 43217, NDC 68084-295-21

## Reason for recall

Failed dissolution specifications: Glipizide 2.5 mg ER  Tablets exceeded  dissolution specification rates for the 10 hour testing point.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0520-2017
- **Recalling firm:** Amerisource Health Services
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-02-03
- **Report date:** 2017-03-22
- **Termination date:** 2018-03-01

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Columbus, OH, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0520-2017

## Citation

> AI Analytics. FDA recall D-0520-2017. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0520-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*